Lv1
20 积分 2022-11-05 加入
Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules
2天前
已完结
Advances in the development of phosphodiesterase 5 inhibitors
2天前
已完结
The 55 % Solution: A Formula for Molecular Recognition in the Liquid State
20天前
已完结
Discovery of ICOS‐Targeted Small Molecules Using Pharmacophore‐Based Screening
8个月前
已完结
Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer
8个月前
已完结
皖公网安备34019202002308
